Nuveen’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Nuveen’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-445,390	Closed	-$1.78M	–	3305
2019 Q4	$1.78M	Buy	445,390 +164,131	+58%	+$771K	﹤0.01%	2472
2019 Q3	$1.38M	Buy	281,259 +18,670	+7%	+$104K	﹤0.01%	2560
2019 Q2	$1.6M	Buy	+262,589	New	+$1.4M	﹤0.01%	2539
2016 Q4	–	Sell	-73,432	Closed	-$2.06M	–	1602
2016 Q3	$2.06M	Buy	73,432 +38,617	+111%	+$1.3M	0.01%	772
2016 Q2	$1.22M	Buy	+34,815	New	+$1.09M	0.01%	950

Other funds holding DPLO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Nuveen's DPLO Position: Q1 2020 in Review

Nuveen sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 445,390 shares — an estimated $1.78M sold.

Nuveen first reported a position in DPLO in Q2 2016 and held it in 5 quarters. The position peaked at $2.06M in Q3 2016. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

Nuveen reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
Nuveen sold 445,390 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $1.78M.
Nuveen first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2016 and held it in 5 quarters.
Nuveen's DIPLOMAT PHARMACY, INC. position peaked at $2.06M in Q3 2016.
1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Nuveen's 13F filing for Q1 2020, filed 14 May 2020.